8-KOther EventsExhibits & Filings

Arthur J. Gallagher & Co. 8-K Report, Corporate Update (Dec 11, 2024)

Filed December 11, 2024For Securities:AJG

Summary

Arthur J. Gallagher & Co. (AJG) announced two significant capital-raising events in its December 11, 2024, 8-K filing. The company successfully closed an offering of approximately 30.4 million shares of common stock, raising over $8.5 billion. This offering was made under a registration statement filed on December 9, 2024. In addition to the equity offering, AJG also entered into an underwriting agreement to issue a substantial amount of senior notes across various maturities. This debt offering, totaling $5 billion, includes tranches ranging from 2027 to 2055 with coupon rates between 4.600% and 5.550%. The company expects to close this debt offering around December 19, 2024, under a shelf registration statement. These capital raises are likely intended to support the company's strategic growth initiatives, including its previously announced acquisition of AssuredPartners, Inc.

Key Highlights

  • 1Completed a common stock offering of 30,357,143 shares for an aggregate purchase price of $8,500,000,040 on December 11, 2024.
  • 2Entered into an underwriting agreement to issue $5 billion in aggregate principal amount of senior notes across five tranches with maturities from 2027 to 2055.
  • 3The notes offering includes tranches of 4.600% due 2027, 4.850% due 2029, 5.000% due 2032, 5.150% due 2035, and 5.550% due 2055.
  • 4The common stock offering was registered on Form S-3 and closed on December 11, 2024.
  • 5The senior notes offering is being made under a shelf registration statement filed on February 12, 2024, with an expected closing around December 19, 2024.
  • 6Risk factors related to the proposed acquisition of AssuredPartners, Inc. (Dolphin Topco, Inc.) have been supplemented and filed.
  • 7The filing includes forward-looking statements regarding the expected benefits and financing of the AssuredPartners acquisition, among other strategic initiatives.

Frequently Asked Questions